Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ureteral Calculi | 4 | 2022 | 110 | 1.330 |
Why?
|
| Ureteroscopy | 7 | 2022 | 142 | 1.290 |
Why?
|
| Kidney Calculi | 7 | 2023 | 465 | 1.170 |
Why?
|
| Nephrostomy, Percutaneous | 5 | 2021 | 85 | 0.960 |
Why?
|
| Nephrolithiasis | 6 | 2012 | 110 | 0.870 |
Why?
|
| Renal Colic | 1 | 2020 | 31 | 0.700 |
Why?
|
| Accounting | 1 | 2019 | 24 | 0.700 |
Why?
|
| Lithotripsy | 3 | 2009 | 143 | 0.690 |
Why?
|
| Time and Motion Studies | 1 | 2019 | 149 | 0.670 |
Why?
|
| Health Care Costs | 2 | 2021 | 3209 | 0.570 |
Why?
|
| Urologic Surgical Procedures | 1 | 2019 | 302 | 0.560 |
Why?
|
| Analgesia | 1 | 2020 | 461 | 0.510 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 694 | 0.470 |
Why?
|
| Analgesics | 1 | 2020 | 1040 | 0.430 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2012 | 83 | 0.400 |
Why?
|
| Citrus | 2 | 2008 | 41 | 0.400 |
Why?
|
| Urinary Calculi | 2 | 2009 | 91 | 0.390 |
Why?
|
| Citric Acid | 2 | 2008 | 126 | 0.390 |
Why?
|
| Lithotripsy, Laser | 3 | 2021 | 46 | 0.360 |
Why?
|
| Robotics | 6 | 2014 | 899 | 0.350 |
Why?
|
| Urolithiasis | 2 | 2022 | 131 | 0.340 |
Why?
|
| Kidney Pelvis | 1 | 2009 | 188 | 0.320 |
Why?
|
| Urination Disorders | 2 | 2008 | 241 | 0.320 |
Why?
|
| Prostatic Hyperplasia | 1 | 2012 | 523 | 0.320 |
Why?
|
| Urinary Diversion | 1 | 2008 | 138 | 0.300 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2007 | 88 | 0.280 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2007 | 162 | 0.270 |
Why?
|
| Beverages | 2 | 2008 | 820 | 0.260 |
Why?
|
| Prostatectomy | 5 | 2014 | 1890 | 0.260 |
Why?
|
| Diseases in Twins | 1 | 2007 | 449 | 0.260 |
Why?
|
| Laser Therapy | 1 | 2012 | 1072 | 0.260 |
Why?
|
| Anesthesia, Local | 1 | 2007 | 275 | 0.260 |
Why?
|
| Stents | 3 | 2021 | 3280 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3158 | 0.240 |
Why?
|
| Prostate | 1 | 2012 | 1774 | 0.230 |
Why?
|
| Metabolic Diseases | 2 | 2007 | 658 | 0.230 |
Why?
|
| Bupivacaine | 1 | 2007 | 411 | 0.230 |
Why?
|
| Urethra | 1 | 2006 | 408 | 0.230 |
Why?
|
| Anesthetics, Local | 2 | 2008 | 985 | 0.230 |
Why?
|
| Fruit | 1 | 2008 | 1142 | 0.210 |
Why?
|
| Laparoscopy | 3 | 2010 | 2151 | 0.200 |
Why?
|
| Rectum | 1 | 2006 | 904 | 0.190 |
Why?
|
| Pain, Postoperative | 2 | 2008 | 1643 | 0.190 |
Why?
|
| Radiography, Abdominal | 2 | 2021 | 537 | 0.170 |
Why?
|
| Cost Savings | 2 | 2023 | 926 | 0.150 |
Why?
|
| Costs and Cost Analysis | 2 | 2021 | 1681 | 0.150 |
Why?
|
| Hydronephrosis | 1 | 1998 | 269 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2021 | 642 | 0.140 |
Why?
|
| Device Removal | 1 | 2021 | 656 | 0.140 |
Why?
|
| Diuretics | 2 | 2009 | 592 | 0.130 |
Why?
|
| Models, Economic | 1 | 2019 | 713 | 0.130 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.120 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 745 | 0.110 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 7659 | 0.110 |
Why?
|
| Workload | 1 | 2019 | 850 | 0.110 |
Why?
|
| Polyurethanes | 1 | 2013 | 107 | 0.110 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2012 | 16 | 0.110 |
Why?
|
| Prostatic Diseases | 1 | 2013 | 56 | 0.110 |
Why?
|
| Volatilization | 1 | 2012 | 82 | 0.110 |
Why?
|
| Potassium Citrate | 2 | 2009 | 8 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2021 | 2250 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 407 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2023 | 5985 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1998 | 808 | 0.100 |
Why?
|
| Acute Disease | 1 | 2021 | 7149 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2014 | 691 | 0.090 |
Why?
|
| Middle Aged | 21 | 2023 | 213383 | 0.090 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2010 | 53 | 0.090 |
Why?
|
| Humans | 34 | 2023 | 744343 | 0.090 |
Why?
|
| Abscess | 1 | 2013 | 607 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2021 | 3528 | 0.080 |
Why?
|
| Nanostructures | 1 | 2013 | 551 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2420 | 0.080 |
Why?
|
| Furosemide | 1 | 2009 | 167 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2013 | 1133 | 0.080 |
Why?
|
| Students, Medical | 1 | 2021 | 1862 | 0.080 |
Why?
|
| Calcium | 2 | 2012 | 5756 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2009 | 571 | 0.080 |
Why?
|
| Calcium Oxalate | 1 | 2007 | 74 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2013 | 1172 | 0.070 |
Why?
|
| Ureteral Obstruction | 1 | 2009 | 296 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2012 | 1050 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2020 | 7729 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 956 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5391 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 687 | 0.070 |
Why?
|
| Male | 20 | 2020 | 350118 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2020 | 40561 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 666 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1998 | 2245 | 0.070 |
Why?
|
| Allopurinol | 1 | 2007 | 191 | 0.070 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 458 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2021 | 5788 | 0.070 |
Why?
|
| Gout Suppressants | 1 | 2007 | 166 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 459 | 0.060 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 723 | 0.060 |
Why?
|
| Logistic Models | 1 | 2020 | 13408 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 57776 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1485 | 0.060 |
Why?
|
| Retrospective Studies | 11 | 2012 | 77449 | 0.060 |
Why?
|
| Equipment Design | 2 | 2013 | 3582 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2022 | 63114 | 0.060 |
Why?
|
| Time Factors | 6 | 2019 | 40075 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1400 | 0.060 |
Why?
|
| Vitamins | 1 | 2012 | 1622 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2007 | 1590 | 0.060 |
Why?
|
| Aged | 11 | 2020 | 163280 | 0.060 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 1261 | 0.060 |
Why?
|
| Mentors | 1 | 2008 | 631 | 0.050 |
Why?
|
| Cysteine | 1 | 2007 | 874 | 0.050 |
Why?
|
| Adult | 11 | 2019 | 214055 | 0.040 |
Why?
|
| Vitamin D | 1 | 2012 | 3223 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 1416 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2023 | 1254 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3760 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39050 | 0.040 |
Why?
|
| Female | 12 | 2020 | 380194 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2007 | 3420 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2014 | 4687 | 0.040 |
Why?
|
| Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
| Swine | 2 | 2014 | 5917 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2014 | 133 | 0.030 |
Why?
|
| Guided Tissue Regeneration | 1 | 2013 | 85 | 0.030 |
Why?
|
| Kidney | 1 | 2009 | 7186 | 0.030 |
Why?
|
| Hypogonadism | 1 | 2019 | 799 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2013 | 335 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.030 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.030 |
Why?
|
| Child | 3 | 2010 | 77709 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2013 | 961 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 232 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 868 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2022 | 53288 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6309 | 0.020 |
Why?
|
| Urinalysis | 1 | 2012 | 369 | 0.020 |
Why?
|
| Materials Testing | 1 | 2013 | 867 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2009 | 11124 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 20129 | 0.020 |
Why?
|
| Urology | 1 | 2014 | 399 | 0.020 |
Why?
|
| Particle Size | 1 | 2013 | 1642 | 0.020 |
Why?
|
| Radioisotope Renography | 1 | 2009 | 62 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 520 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 2008 | 91 | 0.020 |
Why?
|
| Hemorrhagic Disorders | 1 | 2007 | 36 | 0.020 |
Why?
|
| Curriculum | 1 | 2021 | 3605 | 0.020 |
Why?
|
| Neodymium | 1 | 2007 | 21 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2013 | 710 | 0.020 |
Why?
|
| Yttrium | 1 | 2007 | 35 | 0.020 |
Why?
|
| Recurrence | 2 | 2010 | 8340 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 41006 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2007 | 76 | 0.020 |
Why?
|
| Aluminum | 1 | 2007 | 152 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2006 | 25625 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.020 |
Why?
|
| Acoustics | 1 | 2007 | 239 | 0.020 |
Why?
|
| Pelvis | 1 | 2009 | 730 | 0.020 |
Why?
|
| Survival Rate | 1 | 1998 | 12788 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 11031 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 35136 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 662 | 0.010 |
Why?
|
| Animals | 3 | 2014 | 168757 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 1343 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2924 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 2624 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1530 | 0.010 |
Why?
|
| Young Adult | 3 | 2012 | 56430 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 72290 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2008 | 2488 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2013 | 15295 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 29063 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6489 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 9146 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15076 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 2861 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 85781 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 29144 | 0.000 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_